fda drug shortage list tirzepatide reconsidering its decision to take off its Semaglutide taken off FDA's drug
Description
In this disorder, the immune system produces antibodiesprimarily thyroid peroxidase (TPO) antibodies and thyroglobulin antibodiesthat attack the thyroid gland, leading to progressive destruction of thyroid tissue
Semaglutide is an injectable medication originally developed for type 2 diabetes, now FDA-approved for chronic weight management
However, more patients dropped out due to serious side effects, which would be a major problem for frail elderly patients who already have trouble tolerating medications
Symptom-guided therapeutic action is typically required
